Inventor
PELCMAN BENJAMIN
SE27 patents
⚠️ This page may combine multiple inventors who share the name “PELCMAN BENJAMIN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ATROGI AB
7 patentsUS11357757B2Jun 14, 2022
Heteroaryl substituted beta-hydroxyethylamines for use in treating hyperglycaemia
ATROGI AB6 citations85
US11427539B2Aug 30, 2022
Beta-hydroxy heterocyclic amines and their use in the treatment of hyperglycaemia
ATROGI AB3 citations71
US12280023B2Apr 22, 2025
Fluorophenyl beta-hydroxyethylamines and their use in the treatment of hyperglycaemia
ATROGI AB0 citations61
US12036210B2Jul 16, 2024
Heteroaryl substituted beta-hydroxyethylamines for use in treating hyperglycaemia
ATROGI AB0 citations61
US11648216B2May 16, 2023
Fluorophenyl beta-hydroxyethylamines and their use in the treatment of hyperglycaemia
ATROGI AB1 citations61
US12378216B2Aug 5, 2025
Heteroaryl(heterocyclyl)methanol compounds useful in the treatment of hyperglycaemia
ATROGI AB0 citations50
US11793774B2Oct 24, 2023
Chiral beta-hydroxyethylamines and their use in the treatment of hyperglycemia
ATROGI AB0 citations50
PRIEPKE HENNING
5 patentsUS8486968B2Jul 16, 2013
Compounds
PRIEPKE HENNING6 citations71
US8466186B2Jun 18, 2013
Compounds
PRIEPKE HENNING3 citations60
US8951999B2Feb 10, 2015
Compounds
PRIEPKE HENNING2 citations51
US8759537B2Jun 24, 2014
3H-imidazo [4, 5-C] pyridine-6-carboxamides as anti-inflammatory agents
PRIEPKE HENNING1 citations51
US8586604B2Nov 19, 2013
Inhibitors of the microsomal prostaglandin E2 synthase-1
PRIEPKE HENNING1 citations50
OBLIQUE THERAPEUTICS AB
4 patentsUS11208384B2Dec 28, 2021
Sulfinylpyridines and their use in the treatment of cancer
OBLIQUE THERAPEUTICS AB2 citations61
US11168069B2Nov 9, 2021
Heterocyclylsulfonyl-substituted pyridines and their use in the treatment of cancer
OBLIQUE THERAPEUTICS AB1 citations60
US11161815B2Nov 2, 2021
Hydrocarbylsulfonyl-substituted pyridines and their use in the treatment of cancer
OBLIQUE THERAPEUTICS AB2 citations57
US11028067B2Jun 8, 2021
Heteroarylsulfonyl-substituted pyridines and their use in the treatment of cancer
OBLIQUE THERAPEUTICS AB1 citations57
BIOVITRUM AB
3 patentsUS6465467B1Oct 15, 2002
Certain aryl-aliphatic and heteroaryl-aliphatic piperazinyl pyrazines and their use in the treatment of serotonin-related diseases
BIOVITRUM AB72 citations94
US7071180B2Jul 4, 2006
Certain arylaliphatic and heteroaryl-aliphatic piperazinyl pyrazines and their use in the treatment of serotonin-related diseases
BIOVITRUM AB38 citations91
US7534794B2May 19, 2009
Certain arylaliphatic and heteroaryl-aliphatic piperazinyl pyrazines and their use in the treatment of serotonin-related diseases
BIOVITRUM AB12 citations82